中心静脉导管经皮穿刺胸腔引流并腔内注药治疗癌性胸腔积液临床分析  

作　　者：侯龙江 

机构地区：[1]山东东营市广饶县大王镇卫生院,257334

出　　处：《中国社区医师（医学专业）》2012年第35期171-171,176,共2页

摘　　要：目的:探讨利用中心静脉导管经皮穿刺胸腔引流并腔内注药治疗癌性胸腔积液的临床疗效。方法:选择明确诊断的癌性胸腔积液患者80例,随机分引流给药组和穿刺给药组,每组40例,观察两组临床疗效。结果:引流给药组总有效率为87.5%,显著高于穿刺给药组。两者患者不良反应的发生率比较,差异无统计学意义(P<0.05)。结论:中心静脉导管经皮穿刺胸腔引流并腔内注药是治疗癌性胸腔积液安全有效的方法。Objective：To investigate the clinical efficacy of the use of central venous catheter percutaneous thoracic drainage and intracavitary injections in treatment of malignant pleural effusion.Methods：80 cases of a clear diagnosis of malignant pleural effusion effusion patients were randomly divided into drainage treatment group and puncture treatment group,40 cases each.Two groups were compared the differences in clinical efficacy.Results：In the drainage treatment group,the total effective rate was 87.5%,significantly higher than the puncture administration group.Both adverse reactions in patients with the birth rate was no significant difference（P0.05）.Conclusions：The central venous catheter percutaneous thoracic drainage and cavity injection is safe and effective treatment of malignant pleural effusion.

关 键 词：癌性胸腔积液 中心静脉导管 胸腔引流给药 

分 类 号：R730.53[医药卫生—肿瘤]